Commercial clinics advertising repetitive transcranial magnetic stimulation (rTMS) should be approached with caution unless associated with a research institution knowledgeable in the technique. — Whalespan
Commercial clinics advertising repetitive transcranial magnetic stimulation (rTMS) should be approached with caution unless associated with a research institution knowledgeable in the technique.
⚠ High risk
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
◐PARTIALLYSUPPORTED
⚠
High-risk intervention — consult a physician before acting.Drug-drug interactions, dose-dependence, and screening contraindications apply.
“I encourage you to approach those clinics with caution. I'm of the mind that if those clinics are not either closely or maybe even distantly associated with a research institution that's really up on the latest of rTMS, you'd be wise to at least do your research, and explore, talk to other patients who've done these treatments, but certainly in university hospitals and in clinical settings and research settings, rTMS is being used as a way to, for instance, reduce the activity of certain limbic circuitries so that people are just overall less excitable and manic or to activate because it can also be used for activation now of certain neural circuits.”